将减害框架应用于孕期甲基苯丙胺使用:行动呼吁
本文指出孕期甲基苯丙胺使用日益普遍且与不良母婴结局相关,但循证药物干预有限,污名化和社会复杂性导致产前保健不足。作者呼吁开展研究,探讨渐进式减害概念如何应用于使用甲基苯丙胺的产科患者以减轻不良结局。
要点
- 孕期甲基苯丙胺使用增加且与不良母婴结局相关,循证药物干预有限。
- 污名化和社会复杂性导致此类患者产前保健有限,进一步恶化结局。
- 减害框架强调健康促进和安全使用而非戒断,但支持证据有限,需研究。
核心结论
- 呼吁开展研究,探讨减害概念如何应用于使用甲基苯丙胺的产科患者以减轻不良结局。
研究设计与样本
- 本文为行动呼吁类文章,未报告系统检索范围或样本量。
主要发现
- 与阿片类使用障碍相比,甲基苯丙胺使用是公共卫生危机,长期治疗的循证药物干预有限。
- 孕期甲基苯丙胺使用日益普遍,并导致不良母婴结局。
- 污名化和社会复杂性导致此类患者产前保健有限,进一步导致不良结局。
- 减害框架倡导健康促进和安全使用物质,而非追求不可实现的戒断目标,但支持该人群应用的证据有限。
临床怎么用
- 临床应关注孕期甲基苯丙胺使用者的污名化和社会复杂性,并考虑减害框架以改善产前保健和结局。
局限性
- 支持减害应用于孕期甲基苯丙胺使用人群的证据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Compared with opioid use disorder, methamphetamine use is a public health crisis that has limited evidence-based pharmacologic interventions for long-term treatment. The prevalence of methamphetamine use during pregnancy is growing and contributes to adverse maternal and neonatal outcomes. Because of widespread stigma and social complexities associated with methamphetamine use during pregnancy, these patients often experience limited prenatal care, further contributing to poor outcomes. In public health circles, harm reduction describes a framework for conceptualizing substance use by championing health promotion and the safest use of substances, as opposed to the unachievable goal of abstinence. There is limited evidence supporting the application of harm reduction in this population. We call for action and research to investigate how the progressive concept of harm reduction might be applied to mitigate adverse outcomes for obstetrical patients who use methamphetamine.
引用
- Wakeman B, Kremer M, Schulkin J, et al. The application of harm reduction to methamphetamine use during pregnancy: a call to arms. Am J Obstet Gynecol MFM. 2021. PMID: 34102337. doi:10.1016/j.ajogmf.2021.100418
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。